The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice

Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition

(2017) Alba Rodríguez-Nogales et al.   MOLECULAR NUTRITION & FOOD RESEARCH

MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression

(2017) Zhan-Jun Lu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model

(2016) Éricka L. Souza et al.   JOURNAL OF MEDICAL MICROBIOLOGY

miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation

(2016) Xiao-Min Xu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium

(2016) Qianpeng Zhang et al.   Scientific Reports

A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides

(2015) Anita Hartog et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii

(2015) José Garrido-Mesa et al.   PHARMACOLOGICAL RESEARCH

STAMP: statistical analysis of taxonomic and functional profiles

(2014) Donovan H. Parks et al.   BIOINFORMATICS

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

(2014) Aleksandar D. Kostic et al.   GASTROENTEROLOGY

miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses

(2014) Udai P. Singh et al.   IMMUNOLOGY

Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis - authors' reply

(2013) M. Persborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Intestinal microbiota, diet and health

(2013) Susan E. Power et al.   BRITISH JOURNAL OF NUTRITION

microRNA Regulation of Inflammatory Responses

(2012) Ryan M. O'Connell et al.   Annual Review of Immunology

Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1  Production

(2012) M. Haneklaus et al.   JOURNAL OF IMMUNOLOGY

Regulation of TLR4, p38 MAPkinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells

(2012) L. Giahi et al.   Beneficial Microbes

miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells

(2011) H. Zhao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Gut Microbiota, Probiotics and Inflammatory Bowel Disease

(2011) Johannes Stephani et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice

(2011) Natividad Garrido-Mesa et al.   BIOCHEMICAL PHARMACOLOGY

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

(2011) Alan W Walker et al.   BMC MICROBIOLOGY

The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis

(2011) D Camuesco et al.   BRITISH JOURNAL OF PHARMACOLOGY

Microbiota in autoimmunity and tolerance

(2011) Koji Atarashi et al.   CURRENT OPINION IN IMMUNOLOGY

MicroRNA Regulation of Intestinal Epithelial Tight Junction Permeability

(2011) Dongmei Ye et al.   GASTROENTEROLOGY

Recommendations for Probiotic Use—2011 Update

(2011) Martin H. Floch et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Selective Upregulation of microRNA Expression in Peripheral Blood Leukocytes in IL-10-/- Mice Precedes Expression in the Colon

(2011) J. S. Schaefer et al.   JOURNAL OF IMMUNOLOGY

Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis

(2011) Zhen Bian et al.   JOURNAL OF PATHOLOGY

The intestinal microbiota and chronic disorders of the gut

(2011) Andrew W. DuPont et al.   Nature Reviews Gastroenterology & Hepatology

MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development

(2010) Ryan M. O'Connell et al.   IMMUNITY

The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Stimulating Expression of Toll-Like Receptor 5, CD14, MyD88, and TRIF Together with the Induction of Interleukin-8 Expression via the Mitogen-Activated Protein Kinase Pathway in Epithelial Cells

(2010) M. Hafez et al.   INFECTION AND IMMUNITY

Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

(2010) Jian Xu et al.   MOLECULAR CARCINOGENESIS

Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis

(2009) Michael Gersemann et al.   DIFFERENTIATION

Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model

(2009) Hossam M.M. Arafa et al.   FOOD AND CHEMICAL TOXICOLOGY

Probiotics and their derivatives as treatments for inflammatory bowel disease

(2009) Luca Prisciandaro et al.   INFLAMMATORY BOWEL DISEASES

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

(2009) Daniel T Starczynowski et al.   NATURE MEDICINE

The metagenomics RAST server – a public resource for the automatic phylogenetic and functional analysis of metagenomes

(2008) F Meyer et al.   BMC BIOINFORMATICS

Intestinal barrier dysfunction in inflammatory bowel diseases

(2008) Michael A. McGuckin et al.   INFLAMMATORY BOWEL DISEASES